We are happy to announce that MiAlgae, a pioneering biotech company producing sustainable omega-3 (DHA) from microalgae fermentation, has closed its £14M fundraising !
This is an important milestone for the company to accelerate its operations and scale production, in a time where the supply gap for omega-3 is growing faster than ever. Today, most of the omega-3 comes from fish oil from wild fish stocks, a resource whose production has been stagnating for the past 10 years. The aquaculture sector is the main consumer of fish oil and has been the fastest growing food production sector over recent decades with an average annual growth rate of 7% over the past three decades.
MiAlgae is ideally positioned to seize a significant market share while relieving the pressure on wild fish stocks. We at SWEN Capital Partners, through our SWEN Blue Ocean strategy, are delighted to support Douglas Martin and his team alongside Clay Capital and Rabobank !
Learn more: <link to the press release>
Comments